Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Lotus Clinical Research Expands Partnership with Veeva to Accelerate Clinical Trials
Wednesday, May 31, 2023Veeva Systems NYSE VEEV today announced that Lotus Clinical Research expanded its partnership with Veeva and broadened its adoption of Veeva Vault Clinical Suite a strategic move to strengthen its service delivery and efficiency This builds on Lotus...
Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-class ADC Pipeline
Wednesday, May 31, 2023Adcendo ApS Adcendo a biotech company focused on the development of breakthrough antibodydrug conjugates ADCs for the treatment of cancers with high unmet medical need announced the expansion of its current collaboration with Duality Biologics Dualit...
FAR Biotech and Aragen Life Sciences Enter into a Collaboration to Advance Preclinical Program in Neurodegeneration
Wednesday, May 31, 2023Aragen Life Sciences Aragen a leading Contract Research and Development Organization CRO and FAR Biotech FAR a USbased AIdriven computational drug discovery company have announced a collaboration to advance preclinical programs in neurodegeneration A...
C4 Therapeutics and Betta Pharmaceuticals Announce Exclusive Licensing Agreement for the Development and Commercialization in Greater China
Wednesday, May 31, 2023C Therapeutics Inc CT Nasdaq CCCC a clinicalstage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of smallmolecule medicines and transform how disease is treated and Betta Pharmaceutic...
Seal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT for Development of Injectable Formulation of SRT-015 for Acute on Chronic Liver Disease (ACLF)
Wednesday, May 31, 2023Seal Rock Therapeutics Inc a clinical stage company developing firstinclass and bestinclass kinase inhibitors today announced it has entered into an outlicensing agreement with GENFIT Nasdaq and Euronext GNFT for the development of an injectable form...
Charles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSourceSM Laboratory
Wednesday, May 31, 2023Charles River Laboratories International Inc NYSE CRL and Wheeler Bio Inc a contract development and manufacturing organization CDMO today announced an agreement to implement RightSourceSM at Wheeler Bios current good manufacturing practice CGMP biol...
InDex Pharmaceuticals announces license agreement with Viatris Japan to develop and commercialize cobitolimod in Japan
Wednesday, May 31, 2023InDex Pharmaceuticals Holding AB publ InDex today announced that a license agreement has been signed with Viatris Pharmaceutical Japan Inc Viatris Japan to register and commercialize cobitolimod in Japan for the treatment of ulcerative colitis Cobito...
Willow Signs Master Services Agreement With Innovative Biotech Company To Develop Ingredients For Age-related Diseases
Wednesday, May 31, 2023Willow Biosciences IncWillow TSX WLLW OTCQB CANSF a leading biotechnology company focused on revolutionizing industrial manufacturing of pure consistent and sustainable functional ingredients announces execution of a Master Services Agreement the MSA...
Novavax's Nuvaxovid™ Receives Positive CHMP Opinion for Clearance of Full Marketing Authorization for COVID Prevention in the EU
Tuesday, May 30, 2023Novavax Inc Nasdaq NVAX a global company advancing proteinbased vaccines with its novel MatrixM adjuvant today announced that Nuvaxovid NVXCoV has been recommended for full marketing authorization MA for use as a primary series in individuals aged...
Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business
Tuesday, May 30, 2023Avicanna Inc Avicanna or the Company TSX AVCN OTCQX AVCNF FSE NN a biopharmaceutical company focused on the development manufacturing and commercialization of plantderived cannabinoidbased products is pleased to announce the execution of the definiti...
